Effectiveness, Safety, and Methotrexate Dose-Tapering Pattern Over Two Years of Treatment With Adalimumab and ≥12 Mg/Week Methotrexate for Early Rheumatoid Arthritis: Results of the HAWK Postmarketing Surveillance Study in Japan
Modern Rheumatology - United Kingdom
doi 10.1080/14397595.2019.1639931
Full Text
Open PDFAbstract
Available in full text
Date
July 22, 2019
Authors
Publisher
Informa UK Limited